Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer’s disease
Govindarajan Karthivashan, Palanivel Ganesan, Shin‐Young Park, et al.
Drug Delivery (2018) Vol. 25, Iss. 1, pp. 307-320
Open Access | Times Cited: 194

Showing 1-25 of 194 citing articles:

Alzheimer’s disease and its treatment by different approaches: A review
Sukriti Srivastava, Razi Ahmad, Sunil Kumar Khare
European Journal of Medicinal Chemistry (2021) Vol. 216, pp. 113320-113320
Closed Access | Times Cited: 336
Applications of nanotechnology in drug delivery to the central nervous system
Majid Saeedi, Masoumeh Eslamifar, Khadijeh Khezri, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 111, pp. 666-675
Open Access | Times Cited: 291
Temperature-Responsive Multilayer Films Based on Block Copolymer-Coated Silica Nanoparticles for Long-Term Release of Favipiravir
Li Xu, Xingxing Zhang, Zihan Chu, et al.
ACS Applied Nano Materials (2021) Vol. 4, Iss. 12, pp. 14014-14025
Closed Access | Times Cited: 158
Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases
Shima Masoudi Asil, Jyoti Ahlawat, Gileydis Guillama Barroso, et al.
Biomaterials Science (2020) Vol. 8, Iss. 15, pp. 4109-4128
Open Access | Times Cited: 140
Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives
Teresa Pardo-Moreno, Anabel González‐Acedo, Antonio Rivas-Domínguez, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1117-1117
Open Access | Times Cited: 129
Steric Effects in the Deposition Mode and Drug-Delivering Efficiency of Nanocapsule-Based Multilayer Films
Li Xu, Zihan Chu, Jianhua Zhang, et al.
ACS Omega (2022) Vol. 7, Iss. 34, pp. 30321-30332
Open Access | Times Cited: 115
Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases
Palanivel Ganesan, Prakash Ramalingam, Govindarajan Karthivashan, et al.
International Journal of Nanomedicine (2018) Vol. Volume 13, pp. 1569-1583
Open Access | Times Cited: 149
Investigation of the neuroprotective effects of crocin via antioxidant activities in HT22 cells and in mice with Alzheimer's disease
Chunyue Wang, Xueying Cai, Wenji Hu, et al.
International Journal of Molecular Medicine (2018)
Open Access | Times Cited: 113
Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches
Hafza Wajeeha Ejaz, Wei Wang, Minglin Lang
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7660-7660
Open Access | Times Cited: 107
Nanomaterials for the treatment and diagnosis of Alzheimer's disease: An overview
Muhammad Bilal, Mahmood Barani, Fakhara Sabir, et al.
NanoImpact (2020) Vol. 20, pp. 100251-100251
Closed Access | Times Cited: 101
Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations
Yana Zorkina, Olga Abramova, Valeria Ushakova, et al.
Molecules (2020) Vol. 25, Iss. 22, pp. 5294-5294
Open Access | Times Cited: 100
Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases
Maria Inês Teixeira, Carla M. Lopes, Maria Helena Amaral, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 149, pp. 192-217
Closed Access | Times Cited: 97
Nanoparticles: A Hope for the Treatment of Inflammation in CNS
Feng‐Dan Zhu, Yu-Jiao Hu, Lu Yu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 68
The application of exosomes and Exosome-nanoparticle in treating brain disorders
Soodeh Salarpour, Mahmood Barani, Abbas Pardakhty, et al.
Journal of Molecular Liquids (2022) Vol. 350, pp. 118549-118549
Closed Access | Times Cited: 68
Dodging blood brain barrier with “nano” warriors: Novel strategy against ischemic stroke
Suhel Parvez, Medha Kaushik, Mubashshir Ali, et al.
Theranostics (2021) Vol. 12, Iss. 2, pp. 689-719
Open Access | Times Cited: 59
Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease
Rajeev Taliyan, Violina Kakoty, K C Sarathlal, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 528-550
Closed Access | Times Cited: 45
Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date
Bwalya A. Witika, Madan Poka, Patrick H. Demana, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 836-836
Open Access | Times Cited: 45
Kaempferol as a therapeutic agent in Alzheimer’s disease: Evidence from preclinical studies
Xiaoyu Dong, Siyu Zhou, Jianfei Nao
Ageing Research Reviews (2023) Vol. 87, pp. 101910-101910
Closed Access | Times Cited: 39
Reconsidering the role of blood-brain barrier in Alzheimer’s disease: From delivery to target
João André Sousa, Catarina Bernardes, Sara Bernardo-Castro, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 29
Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer’s Disease Management
Sayali Dighe, Sunil Jog, Munira Momin, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 58-58
Open Access | Times Cited: 24
The Psychology of Atopic Dermatitis
Ashling Courtney, John Su
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1602-1602
Open Access | Times Cited: 15
Therapeutic bacteria and viruses to combat cancer: double-edged sword in cancer therapy: new insights for future
Aref Yarahmadi, M. Amin Zare, Masoomeh Aghayari, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 13
New insights into therapeutic applications and nanoformulation approaches of hesperidin: An updated review
Keshav Bansal, Hemant Bhati, Vanshita Singh, et al.
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 10, pp. 100363-100363
Open Access | Times Cited: 10
Exploring Curcumin-Loaded Lipid-Based Nanomedicine as Efficient Targeted Therapy for Alzheimer’s Diseases
Bahareh Farasati Far, Maryam Safaei, Ali Pourmolaei, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 6, pp. 3535-3555
Closed Access | Times Cited: 10
Design, Current States, and Challenges of Nanomaterials in Anti-Neuroinflammation: A Perspective on Alzheimer’s Disease
Xinyang Hong, Tongkai Chen, Yunyun Liu, et al.
Ageing Research Reviews (2025), pp. 102669-102669
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top